Bioliberty raises $3.3 million Series A extension for rehabilitation technology
TGH Ventures, Ballad Ventures, Whiterock and 25m Health joined the financing as Bioliberty develops connected rehabilitation across clinics and homes.
Bioliberty has raised a $3.3 million Series A extension with participation from TGH Ventures, Ballad Ventures, Whiterock and 25m Health. The Edinburgh company develops robotic rehabilitation technology for patients recovering from stroke and other neurological conditions.
Its Lifehub Clinic system combines a soft robotic glove with interactive therapy software. The company plans to connect data across the patient journey and extend its technology into home rehabilitation, while building adoption among US care providers.
The new investors bring healthcare operating relationships alongside capital as Bioliberty develops tools for physical and occupational therapists.
Use of funds
Extend rehabilitation technology into home care and connect therapy data across clinical and home settings
Expand US adoption of robotic rehabilitation systems